A multi-centre prospective controlled trial comparing calcineurin inhibitor monotherapy with sirolimus monthotherapy in hepatitis C infected patients with hepatic fibrosis following liver transplantation

Trial Profile

A multi-centre prospective controlled trial comparing calcineurin inhibitor monotherapy with sirolimus monthotherapy in hepatitis C infected patients with hepatic fibrosis following liver transplantation

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2014

At a glance

  • Drugs Sirolimus (Primary) ; Calcineurin inhibitors
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 17 Oct 2012 This study was discontinued before set-up in England, according to the UK Clinical trials Register.
    • 14 May 2010 New source identified and integrated (ISRCTN: Current Controlled Trials record no. 26350966).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top